United Drug concludes acquisition of Bilcare’s GCS business in US and UK

03 Sep 2012 Evaluate

Bilcare has confirmed the completion of the acquisition of its Global Clinical Supplies (GCS) businesses in the US and the UK, by United Drug plc, a €1.7 billion revenue leading international provider of healthcare services. Bilcare had earlier signed a definitive agreement for the same with United Drug plc.

As a result of the sale, United Drug has acquired Bilcare’s GCS businesses in the US and the UK for $61 million while Bilcare has retained its GCS business in Asia. Going forward, United Drug and Bilcare GCS Asia will work together to use their complementary resources to meet the needs of their global customers across US, Europe and Asia.

Besides, the sale is a significant win-win for Bilcare GCS’s customers and United Drug. It will allow Bilcare GCS Asia to leverage United Drug’s deep capabilities and resources in US and Europe and meet customer requirements in those regions.

Further, Bilcare GCS Asia will continue to build scale by being able to service the Asia-specific needs of United Drug’s customers in US and Europe. Importantly, this agreement will allow Bilcare GCS Asia to focus its resources and better meet customer expectations of world-class services. 

Bilcare Share Price

79.30 -2.91 (-3.54%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Supreme Industries 3367.65
Astral 1458.55
Finolex Inds 169.00
Nilkamal 1375.00
Jain Irrigation Sys 42.27
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×